financetom
Business
financetom
/
Business
/
US FDA approves Axsome Therapeutics' migraine drug
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
US FDA approves Axsome Therapeutics' migraine drug
Jan 30, 2025 1:12 PM

Jan 30 (Reuters) - The U.S. Food and Drug Administration

has approved Axsome Therapeutics' ( AXSM ) migraine treatment,

the company said on Thursday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved